Latest Biotechnology News – Body’s Natural Pain Killing Ability Can Be Boosted

Biotechnology is a bridge between biology, engineering and medicine. It is the study and use of living organisms and their parts to develop technologies and products. Biotechnology has its roots in the natural pain killer development industry. Similarly, pharmaceutical analysis is a field of study that involves chemical, physical, biological and information technologies. A few Recent biotechnology innovations include natural extracts blended with chemical substances that form the basis for drugs to exert therapeutic effects. To study these, the chemical and physical properties of these ingredients and the drugs obtained from them need to be studied.

Modern biotechnology is classified into five branches namely:

1. Human biotechnology
2. Environmental Biotechnology
3. Industrial Biotechnology
4. Animal Biotechnology
5. Plant Biotechnology
   
   

Due to the recent developments in these branches, biotechnology has proven to be effective in addressing various global challenges like disease and hunger. This field of study has enabled humankind to develop products and services that are safer, cleaner and more effective. Most importantly, biotechnology has helped us to develop solutions that are environment friendly and have reduced ecological footprint. Over the past decade, exponential growth has been observed in biotechnological advancements. Not just one field, biotechnology companies have now moved into many sectors including medicine, agriculture, environment and energy.

Latest biotechnology news revolutionizing the industry

According to the latest biotechnology news coming from the University of Michigan, the natural pain killers produced inside our bodies can be enhanced. A study conducted in cells and mice has found that a certain compound can enhance the body’s natural pain-killing ability. The compound has shown fewer side effects than commonly used opioid-based drugs.

Many people who are living with acute and chronic pain in different parts of the body often resort to opioid drugs like fentanyl, oxycodone and morphine for relief. These substances can suppress pain symptoms and offer temporary relief to the users however these come with various side-effects. As a result, the consumer develops an addiction to these drugs and overconsumption often affects other organs and may lead to further complications and even death in certain cases.

Looking at the darker side of opioid-based medicines, scientists have attempted time and again to develop formulas that balance the pain-relieving properties of opioids with their negative side effects. In most of the cases, they have obtained mixed results. However, a recent study has been conducted by a team of scientists and researchers at the University of Michigan to find out formulas that can side-line these side effects and work on the body’s natural ability to block pain.

The mu-opioid receptor

Opioid drugs, whether they come from natural sources like opium or synthetic versions like heroin, work by targeting specific receptors naturally found in the brain and throughout the body. A key receptor involved is the mu-opioid receptor. It usually binds to the body’s natural pain-relieving chemicals, such as endorphins and enkephalins. When opioids bind to this receptor, they mimic these natural painkillers but in a much stronger way. This can lead to powerful pain relief but also carries risks. Because of the mu-opioid receptor’s involvement, these drugs can become addictive and cause side effects, including drowsiness, difficulty breathing, constipation and nausea.

Positive allosteric modulators – a revolutionary finding

According to scientists, under normal circumstances, when someone is experiencing pain, endogenous opioids are being released into the body. The latest theories by these scientists have assumed that these substances called positive allosteric modulators can be used to boost the body’s natural endorphins and enkephalins producing ability. One of the most revolutionary recent biotechnology innovations is a positive allosteric modulator, known as BMS-986122, which can enhance enkephalins’ ability to activate the mu-opioid receptor.

Here are some unique features of positive allosteric modulators:

1. Positive allosteric modulators only work when needed for pain relief.
2. These only work in the presence of endorphins or enkephalins. This means they would only take effect when the body needs pain relief unlike opioid drugs.
3. They bind to the receptors differently, at a different location. This enhances the body’s ability to respond to the body’s pain-relieving compounds.
4. Enkephalins are released in specific regions of the body in a pulsatile fashion.
5. They are metabolized quickly unlike drugs like morphine that outpour the body and brain and stay there for several hours.

The team showcased the modulator’s effectiveness in activating the mu-opioid receptor by isolating and purifying the receptor. Then its response to enkephalins is assessed. By adding the positive allosteric modulator, they found that much lower amounts of enkephalin were needed to achieve the desired response, indicating that the modulator enhances the receptor’s sensitivity to these natural pain-relieving compounds.

A few more electrophysiology and mouse experiments were also conducted. The results showed that the opioid receptor was more strongly activated by the body’s pain-relieving molecules leading to pain relief. With much reduced side effects of depression of breathing, constipation and addiction liability, the modulator seems to be a more effective and safer option for enhancing the body’s natural pain-killing ability. Such positive Biotechnology news brings great hope to mankind regarding discovering nature based side effects-free alternatives to pain relief.

The next step is to measure the ability of the modulator under different conditions. For instance, under conditions of stress or chronic pain, its ability to enhance the activation of endogenous opioids is to be evaluated. This will ensure their effectiveness and safety of use under different conditions without any negative responses like depression of breathing.

Scientists explain that the use of these molecules can greatly reduce the opioid crisis. Patients living with chronic pain can use it to help curb the pain while avoiding the side effects. This type of drug can be used as an alternative to traditional opioids. The fact that these molecules are nature-based ensures that consequences like habit forming and addiction can be avoided.

Biotechnology’s role in social well-being and environment saving is crucial. In the current scenario, there is an essential need for innovative biotechnology applications. Various Biotechnology companies possessing cutting-edge infrastructure, state-of-the-art laboratories and a dynamic curriculum are working in this field to actively promote innovations in biotechnology.